Turing Lengthy Letter Harangues Express Scripts/Imprimis Deal
This article was originally published in Scrip
Turing Pharmaceuticals AG – the company that infamously raised the price of its toxoplasmosis drug Daraprim (pyrimethamine) by more than 5,000% – told three infectious disease groups they were wrong for throwing their support last week behind Express Scripts Holding Co.'s move to add Imprimis Pharmaceuticals Inc.'s compounded formulation of pyrimethamine with leucovorin on the pharmacy benefit management (PBM) company's formulary.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.